CytoSorbents Corp (NAS:CTSO)
$ 0.8 0.0092 (1.16%) Market Cap: 43.45 Mil Enterprise Value: 52.45 Mil PE Ratio: 0 PB Ratio: 2.29 GF Score: 56/100

Q4 2022 Cytosorbents Corp Earnings Call Transcript

Mar 09, 2023 / 09:30PM GMT
Release Date Price: $3.58 (-4.02%)
Operator

Good afternoon, and welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. (Operator Instructions) At this time, I'd like to turn the call over to our moderator, Jodi Hoover. Please go ahead, Mrs. Rover.

Jodi Hoover

Thank you, and good afternoon. Welcome to the Cytosorbents Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Joining me today from the company are Dr. Phillip Chan, Chief Executive Officer; Vincent Capponi, President and Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Efthymios Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Executive Vice President of Sales and Marketing and Managing Director of Cytosorbents Europe GmbH; Christopher Cramer, Senior Vice President of Business Development; and Dr. Irina Kulinets, Senior Vice President of Global Regulatory -- before I turn the call over to Dr. Chan, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements, which are subject to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot